发明名称 Global DNA hypomethylation and biomarkers for clinical indications in cancer
摘要 The present invention provides methods of determination of a global DNA methylation index (GDMI) in a sample from a subject, using a variety of methods which can detect global, genome-wide, and gene-specific DNA methylation to create methylation portraits that can be used for early detection, diagnosis, and clinical management in the personalized medicine space. Further, the invention provides methods of diagnosis of cancer, including gastric cancer and hepatocellular cancer in a subject, by comparing the GDMI in a sample obtained from a subject to the methylation index of standard controls. These methods allow diagnosis of gastric carcinoma and liver cancer in patients who may be asymptomatic or have inconclusive pathology, and allowing earlier treatment of the subject.
申请公布号 US8728732(B2) 申请公布日期 2014.05.20
申请号 US201213408338 申请日期 2012.02.29
申请人 GUERRERO-PRESTON RAFAEL;SIDRANSKY DAVID;THE JOHNS HOPKINS UNIVERSITY 发明人 GUERRERO-PRESTON RAFAEL;SIDRANSKY DAVID
分类号 C12Q1/68;C40B30/04 主分类号 C12Q1/68
代理机构 代理人
主权项
地址